Expression of NUP160 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

NUP160 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 16.37

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

15.3

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	39.4
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	34.1
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	29.5
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	28.9
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	28.6
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	27.5
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	26.7
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	26.6
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	26.0
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	25.0
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	23.7
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	23.3
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	22.7
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	22.4
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	22.0
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	21.9
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	21.5
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	21.1
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	21.1
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	20.7
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	20.7
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	20.3
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	20.1
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	19.9
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	19.8
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	19.8
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	19.8
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	19.8
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	19.7
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	19.2
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	19.1
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	18.9
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	18.5
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	18.5
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	18.4
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	18.4
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	18.3
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	18.3
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	18.1
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	18.1
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	17.9
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	17.9
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	17.3
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	17.3
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	17.3
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	17.1
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	17.1
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	17.0
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	17.0
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	17.0
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	16.9
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	16.8
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	16.4
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	16.3
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	16.1
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	16.1
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	16.1
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	16.1
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	15.7
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	15.7
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	15.7
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	15.4
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	15.3
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	15.2
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	15.1
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	15.1
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	15.1
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	14.9
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	14.9
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	14.8
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	14.8
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	14.7
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	14.6
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	14.6
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	14.5
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	14.5
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	14.2
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	14.2
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	14.0
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	13.7
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	13.7
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	13.7
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	13.4
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	13.4
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	13.1
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	13.1
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	13.0
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	12.6
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	12.5
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	12.5
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	12.5
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	12.4
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	12.3
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	12.2
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	12.1
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	12.1
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	12.0
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	11.8
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	11.6
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	11.3
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	11.2
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	11.1
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	11.1
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	11.0
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	11.0
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	10.9
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	10.9
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	10.9
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	10.8
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	10.8
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	10.8
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	10.8
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	10.6
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	10.4
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	10.3
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	10.3
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	10.3
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	10.1
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	10.0
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	10.0
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	10.0
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	9.9
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	9.8
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	9.7
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	9.3
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	9.2
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	9.2
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	8.9
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	8.8
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	8.7
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	8.5
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	8.3
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	7.9
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	7.9
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	7.6
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	7.2
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	7.0
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	6.8
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	6.8
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	6.8
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	6.6
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

NUP160 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 14.07

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

12.2

Number of samples

Samples

Sample	Description	TPM
AK043	N, NA, stage:NA, alive, 660 days	29.9
AK085	N, NA, stage:NA, alive, 660 days	20.6
AK133	N, NA, stage:NA, dead, 360 days	20.2
AK041	N, NA, stage:NA, alive, 810 days	18.4
AK081	N, NA, stage:NA, dead, 180 days	18.2
AK185	N, NA, stage:NA, alive, 330 days	15.7
AK035	N, NA, stage:NA, dead, 210 days	15.4
AK102	N, NA, stage:NA, alive, 1740 days	15.0
AK003	N, NA, stage:NA, dead, 600 days	14.8
AK123	N, NA, stage:NA, dead, 180 days	14.7
AK089	N, NA, stage:NA, dead, 330 days	14.6
AK165	N, NA, stage:NA, alive, 360 days	14.3
AK124	N, NA, stage:NA, alive, 1920 days	14.2
AK216	N, NA, stage:NA, dead, 360 days	14.0
AK205	N, NA, stage:NA, dead, 120 days	13.9
AK226	N, NA, stage:NA, dead, 360 days	13.8
AK117	N, NA, stage:NA, dead, 210 days	13.8
AK071	N, NA, stage:NA, dead, 540 days	13.2
AK100	N, NA, stage:NA, alive, 960 days	13.1
AK156	N, NA, stage:NA, dead, 330 days	13.1
AK079	N, NA, stage:NA, dead, 210 days	13.0
AK218	N, NA, stage:NA, dead, 180 days	13.0
AK199	N, NA, stage:NA, alive, 1860 days	12.9
AK142	N, NA, stage:NA, alive, 90 days	12.6
AK103	N, NA, stage:NA, alive, 1320 days	12.6
AK227	N, NA, stage:NA, alive, 300 days	12.2
AK051	N, NA, stage:NA, dead, 360 days	11.8
AK068	N, NA, stage:NA, alive, 360 days	11.7
AK053	N, NA, stage:NA, dead, 300 days	11.4
AK099	N, NA, stage:NA, dead, 420 days	11.4
AK074	N, NA, stage:NA, alive, 300 days	11.3
AK030	N, NA, stage:NA, dead, 120 days	11.2
AK149	N, NA, stage:NA, dead, 420 days	10.9
AK231	N, NA, stage:NA, dead, 240 days	10.7
AK236	N, NA, stage:NA, dead, 360 days	10.7
AK139	N, NA, stage:NA, dead, 270 days	10.6
AK167	N, NA, stage:NA, dead, 180 days	10.6
AK173	N, NA, stage:NA, dead, 180 days	10.5
AK055	N, NA, stage:NA, dead, 240 days	10.5
AK005	N, NA, stage:NA, dead, 240 days	10.4
AK195	N, NA, stage:NA, dead, 390 days	10.2
AK178	N, NA, stage:NA, dead, 240 days	10.1
AK098	N, NA, stage:NA, dead, 660 days	10.1
AK076	N, NA, stage:NA, alive, 660 days	9.9
AK049	N, NA, stage:NA, dead, 180 days	9.7
AK091	N, NA, stage:NA, dead, 210 days	9.6
AK188	N, NA, stage:NA, alive, 420 days	9.5
AK158	N, NA, stage:NA, dead, 360 days	9.5
AK072	N, NA, stage:NA, dead, 150 days	9.3
AK088	N, NA, stage:NA, dead, 360 days	9.3
AK002	N, NA, stage:NA, dead, 570 days	9.0
AK153	N, NA, stage:NA, dead, 240 days	8.7
AK066	N, NA, stage:NA, alive, 960 days	8.1
AK213	N, NA, stage:NA, alive, 2010 days	8.0
AK183	N, NA, stage:NA, alive, 360 days	7.9
AK134	N, NA, stage:NA, dead, 360 days	7.6
AK006	N, NA, stage:NA, dead, 360 days	6.3
AK015	N, NA, stage:NA, alive, 720 days	5.5
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0206780003	Tumor	0.7
CPT0224390004	Tumor	0.6
CPT0206230003	Tumor	0.6
CPT0206670004	Tumor	0.6
CPT0207090003	Tumor	0.6
CPT0206560003	Tumor	0.5
CPT0167530003	Tumor	0.5
CPT0224600003	Tumor	0.5
CPT0078580003	Tumor	0.5
CPT0168080003	Tumor	0.5
CPT0217710008	Tumor	0.4
CPT0217190003	Tumor	0.4
CPT0161730003	Tumor	0.4
CPT0205780003	Tumor	0.4
CPT0189850004	Tumor	0.4
CPT0123530003	Tumor	0.4
CPT0189570004	Tumor	0.4
CPT0168590003	Tumor	0.4
CPT0127480003	Tumor	0.4
CPT0162100003	Tumor	0.3
CPT0217430008	Tumor	0.3
CPT0201710003	Tumor	0.3
CPT0167640003	Tumor	0.3
CPT0218830004	Tumor	0.3
CPT0216920008	Tumor	0.3
CPT0182550003	Tumor	0.3
CPT0228220003	Tumor	0.3
CPT0190240004	Tumor	0.3
CPT0218330004	Tumor	0.3
CPT0218890004	Tumor	0.3
CPT0093510003	Tumor	0.3
CPT0175060003	Tumor	0.3
CPT0167970003	Tumor	0.3
CPT0064890003	Tumor	0.3
CPT0217100003	Tumor	0.2
CPT0218770003	Tumor	0.2
CPT0168830003	Tumor	0.2
CPT0093550003	Tumor	0.2
CPT0087570003	Tumor	0.2
CPT0162140003	Tumor	0.2
CPT0092440003	Tumor	0.2
CPT0182500003	Tumor	0.2
CPT0182580003	Tumor	0.2
CPT0071100003	Tumor	0.2
CPT0218690004	Tumor	0.2
CPT0093590003	Tumor	0.2
CPT0225730003	Tumor	0.2
CPT0217060003	Tumor	0.1
CPT0205450004	Tumor	0.1
CPT0127420003	Tumor	0.1
CPT0224540004	Tumor	0.1
CPT0167750004	Tumor	0.1
CPT0205570003	Tumor	0.1
CPT0189250003	Tumor	0.1
CPT0093450003	Tumor	0.1
CPT0206000004	Tumor	0.1
CPT0093360003	Tumor	0.1
CPT0171580008	Tumor	0.1
CPT0189460003	Tumor	0.1
CPT0218960004	Tumor	0.1
CPT0208980003	Tumor	0.1
CPT0217000004	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0186100003	Tumor	0.1
CPT0217880003	Tumor	0.1
CPT0087680003	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0125220003	Tumor	0.1
CPT0087950003	Tumor	0.0
CPT0167860004	Tumor	0.0
CPT0205670004	Tumor	0.0
CPT0225760003	Tumor	0.0
CPT0218670003	Tumor	0.0
CPT0168380003	Tumor	0.0
CPT0168720003	Tumor	0.0
CPT0168480003	Tumor	0.0
CPT0125510003	Tumor	0.0
CPT0168270003	Tumor	0.0
CPT0089150003	Tumor	0.0
CPT0079790003	Tumor	0.0
CPT0189650004	Tumor	0.0
CPT0219080004	Tumor	0.0
CPT0125570003	Tumor	0.0
CPT0190360004	Tumor	0.0
CPT0162020003	Tumor	-0.1
CPT0087730003	Tumor	-0.1
CPT0206110003	Tumor	-0.1
CPT0224330003	Tumor	-0.1
CPT0104330003	Tumor	-0.1
CPT0206330003	Tumor	-0.1
CPT0199770003	Tumor	-0.1
CPT0206880003	Tumor	-0.1
CPT0189750004	Tumor	-0.1
CPT0209440003	Tumor	-0.1
CPT0205890003	Tumor	-0.2
CPT0207030003	Tumor	-0.2
CPT0206450003	Tumor	-0.2
CPT0196850003	Tumor	-0.2
CPT0064650003	Tumor	-0.3
CPT0204330003	Normal	-0.3
CPT0204370003	Normal	-0.3
CPT0104220003	Tumor	-0.4
CPT0204420003	Normal	-0.5
CPT0204410003	Normal	-0.6
CPT0204400003	Normal	-0.6
CPT0204360003	Normal	-0.6
CPT0204350003	Normal	-0.6
CPT0204340003	Normal	-0.6
CPT0204380003	Normal	-0.6
CPT0204390003	Normal	-0.6
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis